Genetic determinants for methotrexate response in juvenile idiopathic arthritis

• Asıl Yazarlar: Serena ePastore (Yazar), Gabriele eStocco (Yazar), Diego eFavretto (Yazar), Sara eDe Iudicibus (Yazar), Andrea eTaddio (Yazar), Pio ed'Adamo (Yazar), Riccardo eAddobbati (Yazar), Giuliana eDecorti (Yazar), Loredana eLepore (Yazar), Alessandro eVentura (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2015-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood and is an important cause of disability. The folic acid analogue methotrexate is the first choice disease-modifying anti-rheumatic drug in this disease, however, 35-45% of patients fail to respond. Molecula...